Hudock, Inc. Gilead Sciences, Inc. Transaction History

Hudock, Inc.

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$59.54 - $68.01 $297 - $340	5 Added 0.22%	2,328 $143,000
Q2 2022 Aug 02, 2022	SELL	$57.72 - $65.01 $6,984 - $7,866	-121 Reduced 4.95%	2,323 $143,000
Q1 2022 May 02, 2022	BUY	$57.92 - $72.58 $17,665 - $22,136	305 Added 14.26%	2,444 $145,000
Q4 2021 Jan 19, 2022	BUY	$64.88 - $73.64 $194 - $220	3 Added 0.14%	2,139 $155,000
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $270 - $292	4 Added 0.19%	2,136 $149,000
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $253 - $277	4 Added 0.19%	2,132 $146,000
Q1 2021 Apr 26, 2021	SELL	$60.0 - $68.46 $18,540 - $21,154	-309 Reduced 12.68%	2,128 $137,000
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $124,573 - $141,945	2,199 Added 923.95%	2,437 $142,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $1,808 - $2,100	25 Added 11.74%	238 $18,000
Q1 2020 Apr 27, 2020	SELL	$62.63 - $80.22 $10,584 - $13,557	-169 Reduced 44.24%	213 $15,000
Q4 2019 Jan 21, 2020	BUY	$61.62 - $67.78 $123 - $135	2 Added 0.53%	382 $24,000
Q3 2019 Oct 31, 2019	BUY	$62.51 - $69.0 $125 - $138	2 Added 0.53%	380 $24,000
Q2 2019 Jul 30, 2019	BUY	$61.87 - $69.38 $61 - $69	1 Added 0.27%	378 $25,000
Q1 2019 Apr 23, 2019	BUY	$62.53 - $70.05 $1,688 - $1,891	27 Added 7.71%	377 $24,000
Q2 2018 Aug 01, 2018	BUY	$64.88 - $75.68 $9,732 - $11,352	150 Added 75.0%	350 $24,000
Q1 2018 Apr 27, 2018	SELL	$72.84 - $88.8 $7,721 - $9,412	-106 Reduced 34.64%	200 $15,000
Q4 2017 Jan 30, 2018	BUY	$71.15 - $83.52 $71 - $83	1 Added 0.33%	306 $21,000
Q2 2017 Aug 08, 2017	BUY	N/A	305	305 $21,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

Stay updated on Hudock, Inc. with notifications on news.